Synthetic double-stranded RNA induces interleukin-32 in bronchial epithelial cells

REFERENCES

• Dahl CA, Schall RP, He HL, Cairns JS: Identification of a novel gene expressed in activated natural killer cells and T cells. J Immunol. 1992;148:597–603.
   PubMed Web of Science ®Google Scholar
• Kim SH, Han SY, Azam T, Yoon DY, Dinarello CA: Interleukin-32: a cytokine and inducer of TNFalpha. Immunity. 2005;22:131–142.
   PubMed Web of Science ®Google Scholar
• Kempuraj D, Conti P, Vasiadi M, Alysandratos KD, Tagen M et al.: IL-32 is increased along with tryptase in lesional psoriatic skin and is up-regulated by substance P in human mast cells. Eur J Dermatol. 2010;20:865–867.
   PubMed Web of Science ®Google Scholar
• Meyer N, Zimmermann M, Bürgler S, Bassin C, Woehrl S et al.: IL-32 is expressed by human primary keratinocytes and modulates keratinocyte apoptosis in atopic dermatitis. J Allergy Clin Immunol. 2010;125:858–865.
   PubMed Web of Science ®Google Scholar
• Ko NY, Mun SH, Lee SH, Kim JW, Kim do K et al.: Interleukin-32α production is regulated by MyD88-dependent and independent pathways in IL-1β-stimulated human alveolar epithelial cells. Immunobiology. 2011;216:32–40.
   PubMed Web of Science ®Google Scholar
• Goda C, Kanaji T, Kanaji S, Tanaka G, Arima K et al.: Involvement of IL-32 in activation-induced cell death in T cells. Int Immunol. 2006;18:233–240.
   PubMed Web of Science ®Google Scholar
• Nakayama M, Niki Y, Kawasaki T, Takeda Y, Horiuchi K et al.: Enhanced susceptibility to lipopolysaccharide-induced arthritis and endotoxin shock in interleukin-32 alpha transgenic mice through induction of tumor necrosis factor alpha. Arthritis Res Ther. 2012;14:R120.
   PubMed Web of Science ®Google Scholar
• Netea MG, Azam T, Ferwerda G, Girardin SE, Walsh M et al.: IL-32 synergizes with nucleotide oligomerization domain (NOD) 1 and NOD2 ligands for IL-1beta and IL-6 production through a caspase 1-dependent mechanism. Proc Natl Acad Sci USA. 2005;102:16309–16314.
   PubMed Web of Science ®Google Scholar
• Arcaroli JJ, Liu N, Yi N, Abraham E: Association between IL-32 genotypes and outcome in infection-associated acute lung injury. Crit Care. 2011;15: R138.
   PubMed Web of Science ®Google Scholar
• Calabrese F, Baraldo S, Bazzan E, Lunardi F, Rea F et al.: IL-32, a novel proinflammatory cytokine in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2008;178:894–901.
   PubMed Web of Science ®Google Scholar
• Meyer N, Christoph J, Makrinioti H, Indermitte P, Rhyner C et al.: Inhibition of angiogenesis by IL-32: possible role in asthma. J Allergy Clin Immunol. 2012;129:964– 973.
   PubMed Web of Science ®Google Scholar
• Kudo M, Ogawa E, Kinose D, Haruna A, Takahashi T et al.: Oxidative stress induced interleukin-32 mRNA expression in human bronchial epithelial cells. Respir Res. 2012;13:19.
   PubMed Web of Science ®Google Scholar
• Li W, Liu Y, Mukhtar MM, Gong R, Pan Y et al.: Activation of interleukin-32 pro-inflammatory pathway in response to influenza A virus infection. PLoS One. 2008;3: e1985.
   PubMed Web of Science ®Google Scholar
• Bai X, Ovrutsky AR, Kartalija M, Chmura K, Kamali A et al.: IL-32 expression in the airway epithelial cells of patients with Mycobacterium avium complex lung disease. Int Immunol. 2011;23:679–691.
   PubMed Web of Science ®Google Scholar
• Schwarze J, Mackenzie KJ: Novel insights into immune and inflammatory responses to respiratory viruses. Thorax. 2013;68:108–110.
   PubMed Web of Science ®Google Scholar
• Jackson DJ, Johnston SL: The role of viruses in acute exacerbations of asthma. J Allergy Clin Immunol. 2010;125:1178–1187.
   PubMed Web of Science ®Google Scholar
• Sapey E, Stockley RA: COPD exacerbations. 2: aetiology. Thorax. 2006;61:250–258.
   PubMed Web of Science ®Google Scholar
• Matsukura S, Kokubu F, Kurokawa M, Kawaguchi M, Ieki K et al.: Synthetic double-stranded RNA induces multiple genes related to inflammation through Toll-like receptor 3 depending on NF-kappaB and/or IRF-3 in airway epithelial cells. Clin Exp Allergy. 2006;36:1049–1062.
   PubMed Web of Science ®Google Scholar
• Kawaguchi M, Fujita J, Kokubu F, Huang SK, Homma T et al.: IL-17F-induced IL-11 release in bronchial epithelial cells via MSK1-CREB pathway. Am J Physiol Lung Cell Mol Physiol. 2009;296: L804–810.
   PubMed Web of Science ®Google Scholar
• Nishida A, Andoh A, Shioya M, Kim-Mitsuyama S, Takayanagi A: Phosphatidylinositol 3-kinase/Akt signaling mediates interleukin-32alpha induction in human pancreatic periacinar myofibroblasts. Am J Physiol Gastrointest Liver Physiol. 2008;294: G831–838.
   PubMed Web of Science ®Google Scholar
• Shioya M, Nishida A, Yagi Y, Ogawa A, Tsujikawa T et al.: Epithelial overexpression of interleukin-32alpha in inflammatory bowel disease. Clin Exp Immunol. 2007;149:480–486.
   PubMed Web of Science ®Google Scholar
• Moon YM, Yoon BY, Her YM, Oh HJ, Lee JS et al.: IL-32 and IL-17 interact and have the potential to aggravate osteoclastogenesis in rheumatoid arthritis. Arthritis Res Ther. 2012;14: R246.
   PubMed Web of Science ®Google Scholar
• Nathan AT, Peterson EA, Chakir J, Wills-Karp M: Innate immune responses of airway epithelium to house dust mite are mediated through beta-glucan-dependent pathways. J Allergy Clin Immunol. 2009;123:612–618.
   PubMed Web of Science ®Google Scholar
• Osterlund C1, Grönlund H, Polovic N, Sundström S, Gafvelin G et al.: The non-proteolytic house dust mite allergen Der p 2 induce NF-kappaB and MAPK dependent activation of bronchial epithelial cells. Clin Exp Allergy. 2009;39:1199–1208.
   PubMed Web of Science ®Google Scholar
• Ioannidis I, McNally B, Willette M, Peeples ME, Chaussabel D et al.: Plasticity and virus specificity of the airway epithelial cell immune response during respiratory virus infection. J Virol. 2012;86:5422–5436.
   PubMed Web of Science ®Google Scholar
• Li W, Sun W, Liu L, Yang F, Li Y et al.: IL-32: a host proinflammatory factor against influenza viral replication is upregulated by aberrant epigenetic modifications during influenza A virus infection. J Immunol. 2010;185:5056–5065.
   PubMed Web of Science ®Google Scholar
• Pera T, Sami R, Zaagsma J, Meurs H: TAK1 plays a major role in growth factor-induced phenotypic modulation of airway smooth muscle. Am J Physiol Lung Cell Mol Physiol. 2011;301: L822–828.
   PubMed Web of Science ®Google Scholar
• Pera T, Atmaj C, van der Vegt M, Halayko AJ, Zaagsma J et al.: Role for TAK1 in cigarette smoke-induced proinflammatory signaling and IL-8 release by human airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol. 2012;303: L272– 278.
   PubMed Web of Science ®Google Scholar
• Goleva E, Jackson LP, Harris JK, Robertson CE, Sutherland ER et al.: The effects of airway microbiome on corticosteroid responsiveness in asthma. Am J Respir Crit Care Med. 2013;188:1193–1201.
   PubMed Web of Science ®Google Scholar
• Dey N, Liu T, Garofalo RP, Casola A: TAK1 regulates NF-KB and AP-1 activation in airway epithelial cells following RSV infection. Virology. 2011;418:93–101.
   PubMed Web of Science ®Google Scholar
• Martel G, Bérubé J, Rousseau S: The protein kinase TPL2 is essential for ERK1/ERK2 activation and cytokine gene expression in airway epithelial cells exposed to pathogen-associated molecular patterns (PAMPs). PLoS One. 2013;8: e59116.
   PubMed Web of Science ®Google Scholar
• Huang F, Kao CY, Wachi S, Thai P, Ryu J et al.: Requirement for both JAK-mediated PI3K signaling and ACT1/TRAF6/TAK1-dependent NF-kappaB activation by IL-17A in enhancing cytokine expression in human airway epithelial cells. J Immunol. 2007;15:6504–6513.
   Google Scholar
• Deng X, Zhang Z, Gu W, Li Y, Liu M: Budesonide inhibits interleukin-32 expression in a rat model of chronic obstructive pulmonary disease. Exp Lung Res. 2012;38:295–301.
   PubMed Web of Science ®Google Scholar